Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Toyobo will start looking at ways to use the knowhow from DMC’s sophisticated fermentation process technologies to enhance the efficiency of making its bioproducts
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
